Upcoming ASM Payment Model Changes and Their Impact on Healthcare Lenders
As specialty care providers prepare for changes in payment and reporting under the Centers for Medicare & Medicaid Services Ambulatory Specialty Model (ASM), healthcare lenders should also take note.
The ASM is a required, five-year payment model with two-sided risk. It starts on January 01, 2027. The model focuses on managing chronic conditions through planned care. It runs from 2027 to 2031, followed by two years for data reporting, payment review, and final adjustments, ending in 2033.
Payment changes apply two years after each performance year, using a timeline similar to the Merit-based Incentive Payment System.
Under the mandate of the Center for Medicare and Medicaid Innovation (CMMI), CMS will keep a portion of redistributed funds to ensure Medicare savings. Payments are based on performance within condition-specific groups, so clinicians are compared with peers treating the same condition.
The ASM relies on the MIPS framework. These measures are still new in practice, so the model will test them before any wider use. Expansion to other specialties may come later.
This model marks a move from voluntary programs to required, clinician-level accountability. It uses a longer time frame to support lasting change. Early participants include specialists treating heart failure and low back pain in selected areas, with the final list expected by summer 2026.
What Healthcare Lenders Should Know
The ASM ties payments to how each clinician performs. This creates more variation in revenue. Practices with strong care processes, good EHR use, and clear coordination will handle this shift better. Others may see unstable payments as accountability moves to the clinician level.
For lenders, operations and data systems now matter more in risk review. Practices that can track episodes, manage referrals, and link pay to outcomes are more likely to keep steady cash flow.
Key points to watch:
- Revenue Risk
The model is required for selected specialists. Payment cuts can reach 9% to 12% by 2033 if cost and quality targets are not met. This creates real downside risk. For lenders that rely on Medicare receivables, these cuts reduce future payments and affect collateral value. - Clinician-Level Risk
Performance is tied to the clinician’s NPI, not the group. If a doctor moves, the risk and any payment changes move with them. This makes revenue less predictable and shifts focus to each provider. - Need for Capital
Practices must invest in EHR tools, data sharing, and care coordination. Some may also add remote monitoring. This can increase demand for financing. - Valuation Pressure
Upside is limited while downside risk is higher. This may lower valuations for some specialties, such as cardiology and pain management, if they are not ready. - Shift to Value-Based Payment
Centers for Medicare & Medicaid Services continues to move away from fee-for-service. Payments now depend more on outcomes. Lenders should review both current revenue and the ability to perform under this model. - Program Overlap
The model overlaps with the Merit-based Incentive Payment System. Some participants may not need to report under MIPS. Practices in multiple programs must manage data and reporting across them.
Summary
ASM brings the required two-sided risk to specialty care. It reduces payment certainty and shifts focus to performance. Lenders need a closer look at operations, data, and clinician-level results when assessing risk.
